Public Citizen Calls on Presidential Candidates, Parties to Pledge Not to Use Dangerous, Manipulative Deepfakes
Statement: FDA Must Reject Tanezumab as a Treatment for Osteoarthritis Due to Unacceptable Dangers, Little to No Benefit
Letter Questioning the Actions of a Senior NIH Scientist and Former AstraZeneca Consultant July 8, 2004
Letter to OHRP Regarding Testing the Drug Canakinumab in Diabetic Children Without Adequate Informed Consent/Parental Permission February 28, 2012
Letter Revealing Heart Dangers in an Unpublished Clinical Trial of Celecoxib (Celebrex) January 31, 2005